17:15 EDT GeoVax Labs files to sell 2.17M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOVX:
- GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
- Is GOVX a Buy, Before Earnings?
- Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review
- GeoVax Labs announces Phase 2 plans for Gedeptin cancer therapy
- GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review